← Open Payments lookup

EILEEN JUSTO: Open Payments

NPI 1689230500 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,266 in 283 payments from 33 companies in 2025. Trend: 2023 $4,674 · 2024 $4,466 · 2025 $5,266

Food & beverage: $5,266
CompanyPaymentsAmount
ABBVIE INC.65$1,048
Novartis Pharmaceuticals Corporation40$414
ACADIA Pharmaceuticals Inc20$382
UCB, Inc.17$350
SK Life Science, Inc.8$331
PFIZER INC.19$320
Biogen, Inc.11$294
Otsuka America Pharmaceutical, Inc.12$233
Genentech USA, Inc.9$208
Celgene Corporation14$177

Products named: QULIPTA, KESIMPTA, NUPLAZID, UBRELVY, NURTEC ODT, REXULTI, Ocrevus Zunovo, ZEPOSIA.

Industry payments across NV — which companies pay providers there.